Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Becton Dickinson & Co.

Submit comprehensive regulatory filing for the Alaris System

Not delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
6 Feb 2020
Due
30 Sep 2020
Checked
8 Oct 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The company expects to submit its comprehensive regulatory filing in the fourth quarter of fiscal year 2020.”
  • SourceBecton Dickinson Form 8-K press release, 2020-02-06
  • FilingSEC filing index
  • Deadline as statedin the fourth quarter of fiscal year 2020
  • Deadline used30 Sep 2020, the last day of the stated period
  • TypeRegulatory
  • Permanent referenceKI-C-2020-BDX-005310
    Cite as https://keptindex.org/c/KI-C-2020-BDX-005310/ — this address never changes.

What we found

Evidence strength A What the grades mean

The company failed to submit the regulatory filing by the end of fiscal year 2020, ultimately submitting the 510(k) premarket notification in April 2021.

  • A
    Becton Dickinson 10-K filed 2020-11-25 Regulatory filing · published 25 Nov 2020 · retrieved 8 Oct 2026 · kept permanently by the SEC · fingerprint b1087cacb0ae
    “We continue to make progress on our regulatory filing related to the BD AlarisTM infusion pumps and we currently expect the filing to be made with the FDA either at the end of the second quarter or early in the third quarter of BD's fiscal year 2021.” ✓ confirmed on the page
  • A
    Becton Dickinson 10-Q filed 2021-08-05 Regulatory filing · published 5 Aug 2021 · retrieved 8 Oct 2026 · kept permanently by the SEC · fingerprint 63d97e2ea279
    “As previously disclosed, we submitted our 510(k) premarket notification to the United States Food and Drug Administration (the “FDA”) for the BD Alaris™ System in April 2021.” ✓ confirmed on the page

Market reaction: the shares moved +2.7% against the S&P 500 over the three sessions around the disclosure (24 Nov 2020 to 30 Nov 2020). What this measures

Checked 8 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Regulatory filing
Indicative materiality
Medium rules
Action
Submit
Deliverable
comprehensive regulatory filing for the Alaris System
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Becton Dickinson? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2020-BDX-005310 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.